{"id":103,"date":"2019-04-10T15:39:53","date_gmt":"2019-04-10T15:39:53","guid":{"rendered":"https:\/\/www.libertymanagement.us\/fda-news\/?p=103"},"modified":"2019-04-17T15:44:33","modified_gmt":"2019-04-17T15:44:33","slug":"national-drug-code-ndc-an-overview","status":"publish","type":"post","link":"https:\/\/www.libertymanagement.us\/fda-news\/2019\/04\/10\/national-drug-code-ndc-an-overview\/","title":{"rendered":"NATIONAL DRUG CODE (NDC) \u2013 AN OVERVIEW"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">According to the Drug listing act of 1972, all registered drug establishments must provide the current list of all drugs manufactured, processed, prepared, propagated, compounded or processed for commercial distribution in their facility to FDA. These drugs products are identified and reported by using a unique three segment number called <a href=\"https:\/\/www.fdahelp.us\/ndc-labeler-code.html\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\" (opens in a new tab)\">National Drug Code (NDC<\/a>), which serves as universal product identifier for human drugs.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.fdahelp.us\/fda-labeler-code.html\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\" (opens in a new tab)\">NDC number<\/a> is a unique 10-digit, 3\u2013segment numeric identifier assigned to each drug listed under Section 510 of FD&amp;C act. Each NDC number identifies the labeler, product and the trade package size of the drug. <\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>The first segment of NDC is known as labeler\ncode, which is a unique 5 digit number assigned by FDA to each establishment\nthat manufactures (including contract manufacturers, re-packers or re-labelers)\nor distributes (under its own name- Private label distributor). <\/li><li>Second segment, which is the product code, identifies\nthe specifications (strength, dosage form and formulation) of a drug for a\nparticular manufacturer.&nbsp; This denotes\nthat different formulations or different strengths of the same formulation\nshould be assigned different product codes.<\/li><li>The third segment, the package code, classifies\npackage sizes and types. The second and third segments of NDC should be\nassigned by the labeler. The NDC will be in one of the following\nconfigurations: 4-4-2, 5-3-2, or 5-4-1.<\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">NDC Labeler code request to FDA\nshould be submitted in SPL (structured Product Labeling) format via FDA ESG\n(electronic submission gateway). Labeler is responsible for each NDC directory\nentry submitted through SPL files.&nbsp; Entry\nin NDC directory doesn\u2019t indicate that FDA approved or verified the information\nof the drug. Assignment of NDC number to non-drug products is strictly\nprohibited. Under FD&amp;C act, registration of a drug establishment or\nassignment of NDC number does not denote that FDA\u2019s approval of the company or\nits products. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Even though NDC number is a\nmandatory requirement, but it is not required to appear on all drug labels and\nincluding the label of any prescription drug carton given to a consumer.&nbsp; However, if the same drug product that are\nsold or used in the hospitals are required to put bar code on their products. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.accessdata.fda.gov\/scripts\/cder\/ndc\/index.cfm\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\" (opens in a new tab)\">NDC Directory<\/a> does not include animal drugs, blood products, API (Active Pharmaceutical Ingredients), drugs manufactured exclusively for a PLD, or drugs that are marketed as a part of a kit or combination product or inner cover of a multi-level packaged product not marketed separately.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a rel=\"noreferrer noopener\" aria-label=\" (opens in a new tab)\" href=\"http:\/\/www.fdahelp.us\" target=\"_blank\">Liberty Management Group Ltd<\/a>, provides assistance with <a rel=\"noreferrer noopener\" aria-label=\" (opens in a new tab)\" href=\"https:\/\/www.fdahelp.us\/fda-drug-registration.html\" target=\"_blank\">drugs establishment registration<\/a><a rel=\"noreferrer noopener\" aria-label=\" (opens in a new tab)\" href=\"https:\/\/www.fdahelp.us\/ndc-labeler-code.html\" target=\"_blank\">, NDC labeler code request<\/a>, <a rel=\"noreferrer noopener\" aria-label=\"Drug Listing (opens in a new tab)\" href=\"https:\/\/www.fdahelp.us\/drug-listing-form.html\" target=\"_blank\">Drug Listing<\/a> and <a rel=\"noreferrer noopener\" aria-label=\" (opens in a new tab)\" href=\"https:\/\/www.fdahelp.us\/fda_registration\/us-fda-agents-requirements.html\" target=\"_blank\">US agent service to foreign facilities<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sudha S<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Regulatory Consultant<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Mail: office@libertymanagement.us<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"http:\/\/www.fdahelp.us\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\" (opens in a new tab)\">http:\/\/www.fdahelp.us<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>According to the Drug listing act of 1972, all registered drug establishments must provide the current list of all drugs manufactured, processed, prepared, propagated, compounded or processed for commercial distribution in their facility to FDA. These drugs products are identified and reported by using a unique three segment number called National Drug Code (NDC), which &hellip; <a href=\"https:\/\/www.libertymanagement.us\/fda-news\/2019\/04\/10\/national-drug-code-ndc-an-overview\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NATIONAL DRUG CODE (NDC) \u2013 AN OVERVIEW&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26,27],"tags":[17,18,2,19],"class_list":["post-103","post","type-post","status-publish","format-standard","hentry","category-fda-registration-drug","category-fda-registration-medical-device","tag-drug-establishment-registration","tag-drug-listing","tag-fda-registration","tag-ndc-labeler-code"],"_links":{"self":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/103","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/comments?post=103"}],"version-history":[{"count":3,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/103\/revisions"}],"predecessor-version":[{"id":106,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/103\/revisions\/106"}],"wp:attachment":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/media?parent=103"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/categories?post=103"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/tags?post=103"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}